U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark One)

[X]  Quarterly  report under Section 13 or 15(d) of the Securities  Exchange Act
     of 1934.

         For the quarterly period ended      September 30, 2000
                                        ----------------------------------------

[ ]  Transition report under Section 13 or 15(d) of the Exchange Act.

         For the transition period from               to
                                        -------------    --------------

                        Commission file number 000-28301

                           ID TECHNOLOGIES CORPORATION
                          ----------------------------
        (Exact Name of Small Business Issuer as Specified in Its Charter)

         North Carolina                                          56-1866233
------------------------------------                          -----------------
   (State or Other Jurisdiction of                             (I.R.S. Employer
   Incorporation or Organization)                            Identification No.)

                        920 Main Campus Drive / Suite 400
                          Raleigh, North Carolina 27606
                    (Address of Principal Executive Offices)

                                 (919) 424-3722
                (Issuer's Telephone Number, Including Area Code)

                                       N/A
                        (Former Name, Former Address and
                Former Fiscal Year, if Changed Since Last Report)

         Check whether the issuer: (1) filed all reports required to be filed by
Section 13 or 15(d) of the  Exchange  Act during the past 12 months (or for such
shorter period that the  registrant was required to file such reports),  and (2)
has been subject to such filing requirements for the past 90 days.

Yes   X      No
   ---------   ----------

         State the number of shares  outstanding of each of the issuer's classes
of common equity,  as of the latest  practicable  date: The issuer had 8,936,514
shares of common stock outstanding as of October 1, 2000.

         Transitional Small Business Disclosure Format (check one):

Yes          No   X
   ---------   ----------
<PAGE>

                                FORM 10-QSB INDEX

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS

PART I        FINANCIAL INFORMATION
              Item 1.      Financial Statements.
              Item 2.      Management's Plan of Operation.

PART II       OTHER INFORMATION
              Item 1.      Legal Proceedings.
              Item 2.      Changes in Securities and Use of Proceeds.
              Item 3.      Defaults Upon Senior Securities.
              Item 4.      Submission of Matters to a Vote of Security Holders.
              Item 5.      Other Information.
              Item 6.      Exhibits and Reports on Form 8-K.

SIGNATURES

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS

         This Form 10-QSB contains  forward-looking  statements.  Any statements
contained in this Form 10-QSB that are not  statements  of  historical  fact are
intended to be and are hereby  identified as  forward-looking  statements within
the  meaning  of the  Private  Securities  Litigation  Reform  Act of  1995.  ID
Technologies  Corporation,  a  North  Carolina  corporation  (the  "Company"  or
"IDTEK")  cautions  readers that  forward-looking  statements  involve known and
unknown risks and uncertainties  which could cause actual results or outcomes to
differ  materially  from  those  expressed  in the  forward-looking  statements.
Forward-looking  statements  include  statements  concerning plans,  objectives,
goals,  strategies,  expectations,  future events or performance  and underlying
assumptions and other  statements  which are other than statements of historical
facts.

         Without limiting the foregoing,  words such as "may," "will," "expect,"
"believe,"  "anticipate,"  "estimate,"  "continue" or comparable terminology are
intended to  identify  forward-looking  statements.  These  statements  by their
nature  involve  substantial  risks and  uncertainties,  and actual  results may
differ  materially  depending  on a variety  of  factors,  many of which are not
within the Company's  control.  These factors  include,  but are not limited to,
economic  conditions  generally  and in the  industries in which the Company may
participate;   competition  within  the  Company's  chosen  industry,  including
competition from much larger competitors; technological advances; and failure by
the  Company  to  successfully   develop  potential   products  and/or  business
relationships and strategic alliances.  In addition to other factors and matters
discussed  elsewhere  herein,  the following are important  factors that, in the
view of the Company,  could cause actual results to differ materially from those
discussed in the  forward-looking  statements:  ability of the Company to obtain
acceptable forms and amounts of financing to fund current and future operations,
research and development and acquisitions;  competition; the Company's operating
losses; the Company's ability to commercially develop its proposed products; the
Company's  ability  to  attract,   hire  and  retain  employees  and  management
personnel;  and the Company's ability to regain control over the development and
exploitation of its technology.  The Company  disclaims any intent or obligation
to  update  these  forward-looking  statements,  whether  as  a  result  of  new
information, future events or otherwise.



<PAGE>




                          PART I FINANCIAL INFORMATION

Item 1.  Financial Statements

ID Technologies Corporation
(A Development Stage Company)
Balance Sheets
                                                    September 30,   December 31,
                                                        2000           1999
                                                     (Unaudited)     (Audited)
                                                     -----------    -----------
Assets
   Cash and cash equivalents                         $   333,323    $    62,986
   Notes receivable                                        3,270          3,270
   Prepaid expenses                                        8,280            150
                                                     -----------    -----------
          Total current assets                           344,873         66,406

   Equipment, net                                          1,320          1,884
   Patents, net                                           14,574         17,562
                                                     -----------    -----------
Total Assets                                         $   360,767    $    85,852
                                                     ===========    ===========

Liabilities and Shareholders' Deficit
    Accounts payable and accrued liabilities         $   154,218    $   122,260
    Note Payable to Protek                                25,987            -
    Note payable to shareholder                           49,217            -
    Convertible debt, net of discount of
      $72,800 and $171,000
      at September 30, 2000
       and December 31, 1999, respectively               327,200        129,000
                                                     -----------    -----------
          Total current liabilities                      556,622        251,260

   Deferred Revenue                                      182,062         93,000

   Long term convertible debt, net
      of discount of $23,204  and $34,166
      at September 30, 2000 and
      December 31, 1999, respectively                    161,796        150,834

Shareholders' deficit:
   Series A Preferred stock, $.001 par
       value; 300,000 shares authorized;
       no shares issued and outstanding                      -              -
   Common stock, no par value,
       50,000,000 shares authorized;
       8,936,514 and 8,277,583 shares
       issued and outstanding at
       September 30, 2000 and
       December 31, 1999, respectively                   282,953        282,953
   Additional paid-in capital                          3,880,630      3,390,859
   Deficit accumulated during
      the developmental stage                         (4,703,296)    (4,083,054)
                                                     -----------    -----------
          Total shareholders' deficit                   (539,713)      (409,242)
                                                     -----------    -----------
Total liabilities and sharehholders' deficit         $   360,767    $    85,852
                                                     ===========    ===========

<PAGE>
<TABLE>
<CAPTION>

ID Technologies Corporation
(A Development Stage Company)
Statements of Operations


                                                                                      Period from
                                                                                  Inception (March 16,
                                        9 months ended          9 months ended       1994) through
                                      September 30, 2000    September  30, 1999   September 30, 2000
                                          (Unaudited)            (Unaudited)          (Unaudited)
                                          -----------            -----------          ------------
<S>                                      <C>                      <C>                 <C>
License revenue                          $        -               $      -            $    92,000
Research and development                       40,270               204,000               703,938
Selling, general and
      administrative expenses                 354,079               335,943             3,774,251
                                          -----------            -----------          ------------
         Loss from Operations                (394,349)             (539,943)           (4,386,189)
Other Income & Expense:
  Interest income - contractual                    95                 1,000                 2,252
  Amortization of debt discount on
        convertible debentures               (187,162)               (6,050)             (253,866)
  Interest expense                            (38,826)              (11,758)              (65,493)
                                          -----------            -----------          ------------
                                             (225,893)              (16,808)             (317,107)
                                          -----------            -----------          ------------

Net Loss                                  $  (620,242)            $(556,751)          $(4,703,296)
                                          ===========            ===========          ============

Basic and diluted loss per common share   $      (.07)            $    (.07)
                                          ===========            ===========

Weighted average number of
    Common shares outstanding               8,374,139             8,243,315
                                          ===========            ===========
</TABLE>


                                             3 months ended     3 months ended
                                           September 30, 2000 September 30, 1999
                                               (Unaudited)        (Unaudited)
                                               -----------       -----------
License revenue                                $        -         $      -
Research and development                             30,270           68,000
Selling, general and
      administrative expenses                       127,163          142,423
                                                -----------      -----------
         Loss from Operations                      (157,433)        (210,423)
Other Income & Expense:
  Interest income - contractual                          95              -
  Amortization of debt discount on
        convertible debentures                      (65,854)          (3,654)
  Interest expense                                  (15,245)          (8,204)
                                                -----------      -----------
                                                    (81,004)         (11,858)
                                                -----------      -----------
Net Loss                                        $  (238,437)     $  (222,281)
                                                ===========      ===========

Basic and diluted loss per common share         $      (.03)     $      (.03)
                                                ===========      ===========

Weighted average number of
    common shares outstanding                     8,450,679        8,378,279
                                                ===========      ===========



<PAGE>


<TABLE>
<CAPTION>


ID Technologies Corporation
(A Development Stage Company)
Statement of Shareholders' Equity (Deficit)
Period from inception (March 16, 1994) through September 30, 2000
                                                                            Deficit
                                                            Additional    Accumulated
                                                             Paid-in        During
                                  Shares         Amount      Capital       Development      Total
                                  ------         ------      -------       -----------      -----

<S>                              <C>            <C>          <C>            <C>           <C>
Balance at March 16, 1994               -      $      -       $     -      $      -       $      -
Issuance of common shares
   for cash and noncash
   consideration                  1,595,200           366            33           -              399
Net loss                                -             -             -            (123)          (123)
                                -----------   -----------   -----------   -----------    -----------

Balance at December 31, 1994      1,595,200           366            33          (123)           276
Issuance of common shares
   for cash and noncash
    consideration                   404,800           -             101           -              101
Net loss                                -             -             -          (2,263)        (2,263)
                                -----------   -----------   -----------   -----------    -----------

Balance at December 31, 1995      2,000,000           366           134        (2,386)        (1,886)

Issuance of common shares
   for cash and noncash
   consideration                  6,000,000           -           1,500           -            1,500

Net loss                                -             -             -         (29,889)       (29,889)
                                -----------   -----------   -----------   -----------    -----------


Balance at December  31, 1996     8,000,000           366         1,634       (32,275)       (30,275)
Issuance of common shares
  for cash, net of
   issuance costs                   153,333       282,587           -             -
                                                                                             282,587
Capital contribution in form
   of research and
   development services                 -             -         201,405           -          201,405
Stock based compensation                -             -       1,333,600           -        1,333,600
Net loss                                -             -             -      (1,684,313)    (1,684,313)
                                -----------   -----------   -----------   -----------    -----------

Balance at December  31, 1997     8,153,333       282,953     1,536,639    (1,716,588)       103,004
Issuance of common shares
   for cash, net of
    issuance costs                   22,500           -          45,000           -
                                                                                              45,000
Capital contribution in form
   of research and
   development services                 -             -         192,319           -
                                                                                             192,319
Stock based compensation                -             -         933,425           -          933,425
Net loss                                -             -             -      (1,426,725)    (1,426,725)
                                -----------   -----------   -----------   -----------    -----------


Balance at December 31, 1998      8,175,833   $   282,953   $ 2,707,383   $(3,143,313)   $  (152,977)
</TABLE>


<PAGE>

<TABLE>
<CAPTION>




                                                                                 Deficit
                                                                  Additional    Accumulated
                                                                   Paid-in       During
                                        Shares       Amount        Capital       Development      Total
                                        ------       ------        -------       -----------      -----
<S>                                  <C>           <C>           <C>           <C>            <C>
Issuance of warrants in connection
   with convertible debt                     -             -         271,870           -          271,870
Capital contribution in form
   of research and
   development services                      -             -         269,441           -          269,441
Issuance of common shares
   for noncash consideration             101,750           -         142,165           -          142,165
Net loss                                     -             -             -        (939,741)      (939,741)
                                     -----------   -----------   -----------   -----------    -----------

Balance at December 31, 1999           8,277,583       282,953     3,390,859    (4,083,054)      (409,242)
Capital contribution in form
   of research and
   development services                      -             -          40,270           -
                                                                                                   40,270
Issuance of common shares
    for noncash consideration            115,987           -          76,050           -
                                                                                                   76,050
Issuance of common shares
   for cash                              542,944           -         295,451           -          295,451
Issuance of options
   in connection with
     convertible debt                        -             -          78,000           -
                                                                                                   78,000
Net Loss                                     -             -             -        (620,242)
                                     -----------   -----------   -----------   -----------    -----------
                                                                                                 (620,242)

Balance at September 30, 2000          8,936,514   $   282,953   $ 3,880,630   $(4,703,296)   $  (539,713)
                                     ===========   ===========   ===========   ===========    ===========

</TABLE>


<PAGE>


<TABLE>
<CAPTION>


ID Technologies Corporation
(A Development Stage Company)
Statements of Cash Flows                                                                     Period from
                                                                                          Inception (March 16,
                                                    9 months ended     9 months ended       1994) through
                                                  September 30, 2000  September 30, 1999  September 30, 2000
                                                     (Unaudited)          (Unaudited)         (Unaudited)
                                                     -----------          -----------         -----------
<S>                                                  <C>                 <C>                 <C>
Cash flows from operating activities:
Net loss                                             $  (620,242)        $  (556,751)        $(4,703,296)
Adjustments to reconcile net loss to
  net cash used in operating activities:
    Depreciation                                             564                 368               1,955
    Amortization                                           2,988               2,990              13,329
    Deferred revenue                                      89,062                 -               182,062
    Stock based compensation                                 -                   -             2,267,025
    Noncash marketing expenses                               -                 4,165              49,165
    Noncash development expenses                          40,270             204,000             705,064
    Noncash professional fees                             76,050                 -               214,050
    Discount on convertible debentures                   187,162               6,050             253,866

    Change in operating assets and liabilities:
          Notes receivable                                   -                10,000              (3,270)
          Prepaids and Deposits                           (8,130)                -                (8,280)
          Accounts payable and accrued liabilities        31,958              30,389             154,218
                                                     -----------         -----------          -----------
Net cash used in operating activities                   (200,318)           (298,789)           (874,112)


Cash flows from investing activities:
   Patent costs                                              -                   -               (27,903)
   Purchase of equipment                                     -                   -                (3,275)
                                                     -----------         -----------          -----------
Net cash used in investing activities                        -                   -               (31,178)

Cash flows from financing activities:
   Proceeds from note payable to shareholder             100,000              65,460             202,750

   Payment of note payable to shareholder                (50,783)           (108,210)           (153,533)
   Proceeds from Notes Payable-Protek                     25,987                 -                25,987
   Proceeds from sale of common stock                    295,451                 -               578,409
   Proceeds from sale of convertible debt                100,000             565,000             665,000
   Payment on convertible debt                               -               (80,000)            (80,000)
                                                     -----------         -----------          -----------
   Net cash provided by financing activities             470,655             442,250           1,238,613
                                                     -----------         -----------          -----------
Increase in cash and cash equivalents                    270,337             143,461             333,323

Cash and cash equivalents, beginning of period            62,986               8,254                 -
                                                     -----------         -----------          -----------
Cash and cash equivalents, end of period             $   333,323         $   151,715         $   333,323
                                                     ===========         ===========          ===========

</TABLE>




<PAGE>



ID Technologies Corporation
(A Development Stage Company)
Notes to Financial Statements
September 30, 2000
(Unaudited)


1.  Management's Opinion
These  financial  statements  should  be read in  conjunction  with the  audited
consolidated  financial  statements and notes thereto  included in the Company's
Form 10-KSB for the fiscal year ended December 31, 1999.

2.       License Agreements
On August 10, 2000, IDTEK issued an exclusive  license for detention  systems to
Bob Barker Company,  Inc. Bob Barker Company paid IDTEK $89,062 for this license
and the license agreement requires Bob Barker Company to pay IDTEK a 10% royalty
on sales of detention  systems utilizing the Company's  technology.  The initial
$89,062  license  fee is  recorded as  deferred  revenue.  The  revenue  will be
recognized over 13.5 years, the remaining life of the patent, on a straight line
basis  beginning in October 2000 in  accordance  with  contract  terms.  The Bob
Barker  Company,  Inc. also  purchased  375,000 shares of IDTEK common stock for
$210,938.

3.  Debt Discount Amortization
Debt discount amortization expense is a non-cash charge to account for the value
of the stock  warrants  and options  granted  debt  holders.  The debt  discount
amortization  expense for the nine months ended September 30, 2000 was $187,162,
of which  $171,000  related to the  Centennial  Venture  Partners (CVP) warrants
valued at $228,000. These warrants are fully amortized as of September 30, 2000.
Without the debt discount  amortization,  the net loss for the nine months ended
September 30, 2000 would be $433,080,  as compared to a net loss of $620,242, as
reported.

4.        Protective Technologies, Inc.
On May 2, 2000,  the Board of  Directors  announced  agreement  in  principal to
purchase Protective Technologies  Incorporated (Protek). In conjunction with the
acquisition,  the  Company  received  a good  faith  deposit  of  $100,000.  The
transaction did not commence and was cancelled on August 2, 2000. IDTEK returned
the deposit to Protek in the form of a 120 day  promissory  note for $25,987 and
137,062  shares of IDTEK  common stock valued at $74,013.  The  promissory  note
bears  interest at a rate of prime,  plus 1%, with interest due and payable with
the principal payment on December 31, 2000.


<PAGE>



5.       Convertible Debt
On  September  18,  2000,  IDTEK  issued  a six  month  convertible  note in the
principal  amount of $100,000 and bearing  interest at 9% per annum.  The holder
had the right during the term of the note to convert,  in whole or in part,  the
$100,000  principal  into 200,000  shares of IDTEK common stock.  The beneficial
conversion  feature  embedded in this agreement was valued at $78,000,  which is
recorded  as a debt  discount  and is  being  amortized  over  the  life  of the
agreement.   Debt  discount  interest  expense  is  a  non-cash   expense.   The
amortization for the nine month period ended September 30, 2000 is $5,200.

6.       Interest Payable
The Company issued  $185,000 of convertible  debentures in April through June of
1999 which carry a 12% annual interest rate payable annually. The first interest
payment was due June 2000. The debenture  holders responded to a written request
to convert their interest  receivable into common shares of the Company at their
then current fair market value of $0.60 per share.  Those who elected to receive
the interest  payment in cash were paid on October 1, 2000 and those who elected
to receive shares in lieu of cash received their shares in October, 2000.

7.       Related Party Transactions
The  money  raised  by the sale of IDTEK  common  stock  to  Centennial  Venture
Partners  (CVP) was for the purpose of hiring an outside  consultant  to perform
services  for IDTEK.  The  consultant  is an  employee  of a member of the IDTEK
board.  The  consultant  was paid $10,000 for his  services.  All services  were
performed by September 30, 2000 and were recorded as  consulting  expenses.  CVP
made the cash payment to the  consultant and was reimbursed by IDTEK in stock as
disclosed in note 8.

8.       Shareholders' Equity (Deficit)
In March and April 2000,  the Company  issued  115,987  shares of common  stock,
valued at  $76,050,  in  exchange  for  professional  services.  IDTEK  realized
$221,438  through  the sale of common  stock in the third  quarter  representing
$210,938  paid by Bob Barker  Company,  Inc.  for its  375,000  shares  which it
purchased in conjunction with its license  agreement (see note 2) and $10,500 of
consulting  services  received  through  Centennial  Venture Partners for 30,882
shares of IDTEK common stock (see note 7).

9.       Subsequent Events
On September 24, 1999,  the Company issued a $300,000  convertible  debenture to
Centennial Venture Partners.  The convertible  debenture,  by its terms,  became
payable  on  demand  on or after  September  24,  2000.  On  October  16,  2000,
Centennial  Venture  Partners  called the  debenture  and the Company paid it in
full, together with accrued interest of $26,600, on October 25, 2000.

On October 30, 2000, a $100,000  convertible  note that was issued September 18,
2000 at 9% interest with an option to purchase 200,000 shares at $0.50 per share
(see Note 5) was settled through the issuance of 250,000 shares of voting common
stock and an option to purchase an additional  250,000 shares at $0.40 per share
over a period of 2 years.  The  original  option to purchase  200,000  shares at
$0.50 per share was cancelled in conjunction with the settlement.

<PAGE>

In-Q-Tel has issued a non-binding letter of intent to invest $400,000 in IDTEK.

On October 20, 2000,  IDTEK entered into a binding  agreement  with PROTEK which
cancelled the nonexclusive license agreement granted to PROTEK on March 30, 1999
and granted PROTEK five individual  exclusive licenses in the fields of medical,
medical  insurance,  private  credit,  gaming,  and mass  transit.  The medical,
medical  insurance and private credit exclusive  licenses require PROTEK to make
royalty  payments  to the Company  equal to 5% of PROTEK's  sales of products in
these fields and the gaming and mass  transit  licenses  require  PROTEK to make
royalty  payments  to the Company  equal to 7% of PROTEK's  sales of products in
these categories.  At present,  the Company does not yet have a saleable product
so no royalties will be earned in the near future, if at all.

On or about  October 25,  2000,  the Company  borrowed  $50,000 from a financial
institution,  with  principal  due six months  after the  borrowing  and bearing
interest at 12% per annum.  This borrowing was personally  guaranteed by each of
the Company's Chairman and Chief Executive Officer.

Item 2.  Management's Plan of Operation.

         The Company is engaged in the  development  of biometric  technologies,
know-how, and products for licensing worldwide. The Company holds the patent for
a card,  panel,  or substrate  allowing  "on-board"  storage and  authentication
(identification)  of  fingerprints.  The  Company  estimates  the  size  of  the
potential market for such products to be 1/10 trillion dollars. The applications
for this technology are many and varied:  from welfare cards to  loyalty/medical
records/personal  information  cards to  controlling  the use of firearms to one
user.

         The development and production of this biometric  technology is managed
by the Company's scientific partner,  Information  Resources Engineering ("IRE")
of  Baltimore,  Maryland.  IRE is a leading  provider  of network  and  internet
security systems and technologies.  IRE is a shareholder of the Company,  owning
13.7% of the  Company's  outstanding  common  stock.  IRE also  holds a  Company
license  with rights to the  internet,  computer  network,  banking and treasury
fields worldwide.

         A prototype  card was completed at the end of the Company's 1999 fiscal
year,  as well as a  comprehensive  manufacturing  plan to  build a  single-chip
production card at a cost below $20. The  non-recurring  engineering  cost (NRE)
will be paid by IRE to the production card maker at a cost of approximately $1.7
million.

         Presently,  the Company has initial licenses in place with IRE, PROTEK,
Power^Up Marketing Corporation,  BrentScott Associates and Revolution Labs which
are expected to yield $800,000 in initial license fees,  collectively,  when the
Company's card begins production. Production is expected to begin in 2001.

         The Company believes it has to be the  first-to-market  leader with the
following competitive advantages:

<PAGE>

o    A  biometric  fingerprint  card with  storage and a power  source  (lithium
     battery) on board.
o    A biometric fingerprint card not requiring an independent power source.
o    A biometric  fingerprint card safe-guarding  personal privacy (a government
     or corporate-based database system is unnecessary).
o    A biometric  fingerprint  card with 113 m.p.s of computing power (the power
     of a Palm Pilot).

The biometric  fingerprint  card is essentially a standalone  computer on a card
protected by the Lane foundation  patent:  United States Patent Number 5,623,552
issued on April 22, 1997.

         The  Company  has  been  a  developmental-stage  company  with  nominal
revenues since its inception.  Losses were $1,426,725 in 1998, $939,741 in 1999,
$556,571 in the nine months  ended  September  30, 1999 and $620,242 in the nine
months ended September 30, 2000.

         As of November 1, 2000, the Company had  approximately  $7,000 in cash.
The Company needs to raise at least $250,000 to fund current year operations and
at least an additional $550,000 to fund the Company's  operations until the time
the  Company  believes  its  product  under  development  will begin to generate
sufficient  revenues to fund  operations,  which the Company expects to occur in
the  last  quarter  of  2001.  As  of  November  1,  the  Company  had  cash  of
approximately $7,000.  Accordingly,  the Company has an immediate need for cash.
There  is no  assurance  that  the  Company  will be able to  raise  this or any
additional amount which becomes required.

         With  the  Company's   policy  of  contracting   out   development  and
concentrating  on licensing of its intellectual  property,  the Company does not
plan to  purchase  any  equipment  or buy or rent  plant(s)  in the  next  year.
Nonetheless,  when and if at least  $800,000 is raised,  the Company  intends to
hire a  high-level  engineer to oversee  the  Company's  multi-development  card
projects and assist the  Company's  licensees  with their  particular  biometric
applications.

         Results of Operations

         The following  discussion provides an analysis of the Company's results
of  operations  and  liquidity  and  capital  resources.  This should be read in
conjunction with the financial  statements of the Company and notes thereto. The
operating results of the periods presented were not affected by inflation.

         Comparison of Nine Months Ended September 30, 2000 and 1999:

         There was no license  or  royalty  revenue  for the nine  months  ended
September 30, 2000 or 1999. ID Technologies sold a license to Bob Barker Company
for an initial license fee of $89,062 during the third quarter of 2000, but this
will be recorded as license  revenue over the  remaining  13.5-year  term of the
patent  underlying  the  license.  Other  one  time  license  fee  payments  are
predicated  primarily  on the Company (or its contract  partners)  being able to
produce a $20 cost biometric  fingerprint  production card. Royalty payments are
predicated on the sale of the cards to end-users by the licensees.

<PAGE>

         The research  and  development  expenses  are a non-cash  entry in both
periods,  which mirrors exactly IRE's research and development cash expenses for
the  development  of  the  biometric   fingerprint   card.  IRE's  research  and
development  cost for the card was $40,270 for the nine months  ended  September
30, 2000 compared to $204,000 for the nine months ended September 30, 1999. Even
though  IRE,  the  Company's  development  partner  and  13.7%  shareholder,  is
responsible  for and incurred  this  expense,  ID  Technologies  must record the
expense since the Company receives the benefits from IRE's research.

         Selling,  general,  and administrative  expenses during the nine months
ended September 30, 2000 were $354,079, up 5% from the $335,943 of such expenses
in the prior year period due to an increase in insurance  costs and  commissions
paid to issue short term debt and a license agreement.

         Amortization of debt discount on convertible debentures was $187,162 in
the first nine months of 2000 compared to $6,050 in the first nine months of the
1999 fiscal  year.  This is a non-cash  expense to amortize the value of options
and warrants  associated with the $485,000 of convertible  debt obtained in 1999
and the $100,000 of convertible debt obtained third quarter 2000.

         Interest  expense was $38,826 in the first nine months of 2000, up from
the  $11,758  recorded  in the first nine months of 1999.  This  represents  the
accrued interest of 12% on $185,000  convertible  debentures issued in mid-1999,
8% interest on $300,000  convertible  debentures issued in September 1999, 14.5%
on $50,000 note payable issued June 2000,  prime plus 1% on $25,987 note payable
issued August 2000, and 9% on $100,000  convertible  note issued September 2000.
The  debt  outstanding  in the  first  nine  months  of 1999  was  the  $185,000
convertible debentures issued mid-1999 and a small note from a shareholder.

         The Company's net  operating  loss for the nine months ended  September
30, 2000 was $394,349,  down 27% from the net operating loss of $539,943 for the
nine months  ended  September  30, 1999.  The Company is delaying the  necessary
development and marketing  expenditures  until it obtains  additional  financing
that will provide working capital.

                            PART II OTHER INFORMATION

Item 1.  Legal Proceedings.

         The Company is not involved in any pending legal proceeding.

Item 2.       Changes in Securities and Use of Proceeds.

         On August 2, 2000, the Company settled a dispute with PROTEK concerning
its payment to the Company of a $100,000  earnest  deposit in connection  with a
potential  acquisition  with the  Company  which  was  terminated.  The  parties
disagreed  as to whether  the Company was  entitled to retain this  deposit.  To
settle  that  disagreement,  on August 2,  2000 the  Company  issued to PROTEK a
promissory note in the principal  amount of $25,987  bearing  interest at prime,
plus 1% and payable December 31, 2000 and 137,062 shares of the Company's common
stock having a fair market at the time of issuance, based on the market price of
the stock at that time, of $74,013.

<PAGE>

         On August 10, 2000,  the Company sold 375,000  shares of the  Company's
common stock to Bob Barker Company, Inc. for a cash payment of $210,938. The Bob
Barker  Company  purchased  the  shares in the  Company in  connection  with its
purchase of an exclusive license for detention systems from the Company.

         On or about September 30, 2000, the Company issued to CVP 30,882 shares
of the Company's common stock, with a value based on the stock's market price at
the time of the  issuance  of $10,500,  to  reimburse  CVP for the $10,000  cash
payment it made to a consultant  of the Company to pay for services  rendered by
the   consultant  to  the  Company,   with  the  remaining   $500   representing
consideration to CVP for making the cash payment.

         On  September  18,  2000,  the  Company  issued a  $100,000  six  month
convertible note to a purchaser which was convertible into 200,000 shares of the
Company's  common stock.  On October 30, 2000, the Company and the holder of the
convertible note, settled the note in full through the Company's issuance to the
holder of 250,000 shares of the Company's  common stock and a two year option to
purchase  an  additional  250,000  shares of the  Company's  common  stock at an
exercise price of $0.40 per share.

         The Company  relied on Section 4(2) of the  Securities  Act of 1933, as
amended, for the securities  registration  exemption in each of these placements
since each  involved a privately  negotiated  transaction  with a  sophisticated
investor, each of whom had a pre-existing business relationship with the Company
and/or its affiliates.

Item 3.       Defaults Upon Senior Securities.

         None.

Item 4.  Submission of Matters to a Vote of Security Holders.

         None.

Item 5.       Other Information.

         None.



<PAGE>




Item 6.       Exhibits and Reports on Form 8-K.

         (a)      Exhibits.
                  ---------
Exhibit
  No.                                            Description
-------                                          -----------

3.1                         Articles  of   Incorporation,   together   with  all
                            amendments   thereto.    (Incorporated   herein   by
                            reference  to  Exhibit  2.01 of the  Company's  Form
                            10-SB filed as of November 30, 1999.)

3.2                         Bylaws.   (Incorporated   herein  by   reference  to
                            Exhibit  2.02 of the  Company's  Form 10-SB filed as
                            of November 30, 1999.)

4.1                         Form of  Debenture  Purchase  Agreement by and among
                            the  Company and  purchasers  of the  Company's  12%
                            Convertible   Subordinated   Debentures   due  2002.
                            (Incorporated  herein by  reference  to Exhibit 3.01
                            to the  Company's  Form 10-SB  filed as of  November
                            30, 1999.)

4.2                         Form of 12% Convertible  Subordinated  Debenture Due
                            2002.  (Incorporated  herein by reference to Exhibit
                            3.02  to  the  Company's  Form  10-SB  filed  as  of
                            November 30, 1999.)

4.3                         Registration Rights Agreement,  dated as of December
                            31, 1997,  between the Company and Hutchison & Mason
                            PLLC.  (Incorporated  herein by reference to Exhibit
                            3.04  to  the  Company's  Form  10-SB  filed  as  of
                            November 30, 1999.)

4.4                         Stock  Purchase  Agreement,  dated as of  August  1,
                            1997,  by  and  among  the  Company,  Li-Pei  Wu and
                            William  F.  Lane (as agent  for  certain  sellers),
                            together with Addendum to Stock  Purchase  Agreement
                            of even  date  therewith.  (Incorporated  herein  by
                            reference  to  Exhibit  3.04 to the  Company's  Form
                            10-SB filed as of November 30, 1999.)

4.5                         Convertible  Debenture,  dated  September  24, 1999,
                            made by the Company in favor of  Centennial  Venture
                            Partners,  LLC  ("CVP").   (Incorporated  herein  by
                            reference  to  Exhibit  3.05 to the  Company's  Form
                            10-SB filed as of November 30, 1999.)
4.6                         Common Stock Purchase  Warrant,  dated September 24,
                            1999,  made by the Company in favor of CVP  (450,000
                            shares).   (Incorporated   herein  by  reference  to
                            Exhibit 3.06 to the Company's Form 10-SB filed as of
                            November 30, 1999.)
4.7                         Common Stock Purchase  Warrant,  dated September 24,
                            1999,  made by the Company in favor of CVP  (150,000
                            shares).   (Incorporated   herein  by  reference  to
                            Exhibit 3.07 to the Company's Form 10-SB filed as of
                            November 30, 1999.)

4.8                         Common Stock Purchase  Warrant,  dated September 24,
                            1999,  made by the Company in favor of CVP  (200,000
                            shares).   (Incorporated   herein  by  reference  to
                            Exhibit 3.08 to the Company's Form 10-SB filed as of
                            November 30, 1999.)

4.9                         Common Stock Purchase  Warrant,  dated September 24,
                            1999,  made by the  Company  in  favor of CVP (up to
                            $500,000).  (Incorporated  herein  by  reference  to
                            Exhibit 3.09 to the Company's Form 10-SB filed as of
                            November 30, 1999.)

4.10                        Investor Rights Agreement, dated as of September 24,
                            1999,  by and among the Company and certain  holders
                            of  its  capital  stock.   (Incorporated  herein  by
                            reference  to  Exhibit  3.10 to the  Company's  Form
                            10-SB filed as of November 30, 1999.)

4.11                        Shareholders Agreement, dated September 24, 1999, by
                            and among the Company and certain  shareholders  and
                            investors.  (Incorporated  herein  by  reference  to
                            Exhibit 3.11 to the Company's Form 10-SB filed as of
                            November 30, 1999.)

10                          License Agreement with Bob Barker Company, Inc.

27                          Financial Data Schedule.




(b)      Reports on Form 8-K.

         None



<PAGE>




                                   SIGNATURES

         In accordance with the requirements of the Exchange Act, the registrant
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

                                       ID TECHNOLOGIES CORPORATION


                                    BY       /S/ J. Phillips L. Johnston
                                      ------------------------------------------
DATE:    November 14, 2000            J. Phillips L. Johnston, President and CEO

                                            /S/ William F. Lane
                                      ------------------------------------------
DATE:    November 14, 2000            William F. Lane, Chairman and Treasurer
                                      (Principal Financial Officer)